# Objective Evaluation of Intradermal MSC-Derived Exosome Therapy on Facial Skin Quality

> **NCT07466953** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Mert Ersan** · enrollment: 30 (estimated)

## Conditions studied

- Skin Aging
- Facial Aging
- Skin Quality

## Interventions

- **BIOLOGICAL:** Mesenchymal Stem Cell-Derived Exosome

## Key facts

- **NCT ID:** NCT07466953
- **Lead sponsor:** Mert Ersan
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-01
- **Primary completion:** 2026-12-01
- **Final completion:** 2026-12-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07466953

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07466953, "Objective Evaluation of Intradermal MSC-Derived Exosome Therapy on Facial Skin Quality". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07466953. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*